Organon & Co. (OGN)

NYSE: OGN · USD

$13.8

+0.02 (+0.1%)· Recorded snapshot

Market cap	3.6B
Revenue (ttm)	6.1B
Net income (ttm)	209M
EPS (ttm)	$0.79
Shares out	262.6M
P/E (trailing)	17.4x
P/E (forward)	3.8x
Dividend	$0.08 (0.58%)
Volume	2,568,633
Beta	1.54

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 6.1B
Net income (ttm): 209M
EPS (ttm): $0.79
P/E (trailing): 17.4x
P/E (forward): 3.8x
Market cap: 3.6B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Giữ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E3.8

P25 n/aP50 n/aP75 n/a

Trailing P/E17.4

P25 n/aP50 n/aP75 n/a

ROE24

P25 n/aP50 n/aP75 n/a

ROIC6.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All OGN indicators

Market & fundamental data

Available fields

265

Groups with data

Currency

USD

Showing 265 of 265 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001821825
Company name	Organon & Co.
Country	United States
Country code	US
CUSIP number	68622V106
Earnings date	2026-11-09
Earnings time	bmo
Employees	10,000
Employees change	0
Employees growth	0%
Enterprise value	$11B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1923
Industry	Drug Manufacturers - General
Is primary listing	Yes
Is SPAC	No
ISIN number	US68622V1061
Last 10-K release date	2026-02-24
Last earnings date	2026-07-31
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$3.6B
Market cap category	Mid-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$13.77
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	OGN
U.S. state	New Jersey
Website	https://www.organon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	4.3x
Average P/E ratio (3Y)	6.41x
Average P/E ratio (5Y)	6.57x
Earnings yield	5.76%
EV/Earnings	52.82x
EV/EBIT	9.12x
EV/EBITDA	7.06x
EV/FCF	19.47x
EV/Sales	1.8x
FCF / EV yield	5.14%
FCF yield	15.67%
Forward EV/Sales	1.76x
Forward P/E	3.82x
Forward P/S	0.58x
Graham number	8.26692
Graham upside	-39.99%
Industry forward P/E	18.59x
Industry P/E	36.43x
Lynch fair value	$3.96
Lynch upside	-71.22%
P/(FCF - SBC) ratio	7.35x
P/(OCF - SBC) ratio	5.46x
P/B ratio	3.59x
P/E ratio	17.36x
P/FCF ratio	6.38x
P/OCF ratio	4.91x
P/S ratio	0.59x
Price/EBITDA ratio	2.31x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	19.75%
EBITDA margin	25.53%
Effective tax rate	57.43%
FCF margin	9.25%
Gross margin	53.4%
Operating margin	19.75%
Pretax margin	8.01%
Profit margin	3.41%
Profit per employee	$20,900
Profitable quarters	2
Profitable years	8
Revenue per employee	$612,700
ROA	5.67%
ROA (5Y)	8.46%
ROCE	11.46%
ROE	24.04%
ROIC	6.14%
ROIC (5Y)	15.52%
SBC / revenue	1.22%
Tax / revenue	4.6%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-70.5%
EPS growth (Q)	-28.29%
EPS growth (QoQ)	-27.27%
EPS growth 3Y	-35.47%
EPS growth 5Y	-35.04%
EPS growth years	0
FCF growth	-13.83%
FCF growth (Q)	-64.09%
FCF growth (QoQ)	-65.43%
FCF growth 3Y	4.99%
FCF growth 5Y	-25.65%
Gross profit growth	-8.14%
Gross profit growth (Q)	-5.15%
Gross profit growth 3Y	-4.96%
Gross profit growth 5Y	-4.09%
Net income growth	-70.14%
Net income growth (Q)	-25.52%
Net income growth (QoQ)	-26.03%
Net income growth 3Y	-34.8%
Net income growth 5Y	-34.56%
Net income growth years	0
OCF growth	-10.78%
OCF growth (Q)	-51.36%
OCF growth (QoQ)	-52.44%
OCF growth 3Y	0.55%
OCF growth 5Y	-23.21%
Operating income growth	-12.06%
Operating income growth (Q)	-6.38%
Operating income growth 3Y	-6.74%
Operating income growth 5Y	-11.45%
Revenue growth	-2.45%
Revenue growth (Q)	-2.26%
Revenue growth (QoQ)	6.71%
Revenue growth 3Y	-0.22%
Revenue growth 5Y	-0.64%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-170M
Depreciation and amortization	$354M
EBIT	$1.2B
EBITDA	$1.6B
EPS	$0.79
FCF per share	$2.16
Financing cash flow	$-313M
Free cash flow	$567M
Free cash flow minus SBC	$492M
Gross profit	$3.3B
Income taxes	$282M
Investing cash flow	$130M
Net borrowing	$-286M
Net cash flow	$533M
Net income	$209M
Operating cash flow minus SBC	$662M
Operating income	$1.2B
Revenue	$6.1B
Stock-based compensation	$75M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.26
Book value per share	$3.83
Debt / EBITDA	5.23
Debt / equity	8.5
Debt / FCF	15.08
Goodwill	$4.2B
Interest coverage	2.59
Long-term assets	$8.1B
Long-term liabilities	$9.6B
Net cash (debt)	$-7.4B
Net cash / market cap	-205.14%
Net debt / EBITDA	4.74
Net debt / equity	7.38
Net debt / FCF	13.09
Piotroski F-Score	6
Property, plant and equipment	$1.3B
Shareholders' equity	$1B
Tangible book value	$-4.3B
Tangible book value per share	$-16.22
Total assets	$13.2B
Total cash	$1.1B
Total debt	$8.6B
Total liabilities	$12.2B
WACC	5.42%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.46
Current assets	$5.1B
Current liabilities	$2.6B
Current ratio	1.95
Inventory turnover	2.04
Net working capital	$1.4B
Quick ratio	1
Working capital	$2.5B
Working capital turnover	2.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.39%
Dividend growth	-86.67%
Dividend growth (3Y)	-58.51%
Dividend growth years	0
Dividend payment date	2026-09-10
Dividend payment years	6
Dividend payout frequency	Quarterly
Dividend per share	$0.08
Dividend yield	0.58%
Ex-dividend date	2026-08-14
FCF payout ratio	3.71%
Last dividend	$0.02
Payout ratio	10.09%
Shareholder yield	-0.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$12.75
1D price change	0.11%
1M price change	0.33%
1M total return	0.33%
1W price change	0.11%
1W total return	0.11%
1Y price change	95.11%
1Y return CAGR	96.8%
1Y total return	96.7%
20-day SMA	$13.75
200-day SMA	$11.46
3M price change	1.74%
3M total return	1.88%
3Y price change	-7.92%
3Y return CAGR	1.12%
3Y total return	3.41%
50-day SMA	$13.73
50-day SMA vs 200-day SMA	50over200
52-week high	$13.83
52-week high date	2026-10-09
52-week low	$5.69
52-week low date	2026-03-30
5Y price change	-61.44%
5Y return CAGR	-14.02%
5Y total return	-53%
6M price change	4.67%
6M total return	4.98%
All-time high	$39.48
All-time high date	2022-03-02
All-time low	$5.69
All-time low date	2026-03-30
Average true range (ATR)	$0.04
Average volume	2.2M
Beta (1Y)	2.35
Beta (2Y)	0.91
Beta (5Y)	1.54
Change from 52-week high	-0.47%
Change from 52-week low	141.92%
Change from all-time high	-65.1%
Change from all-time low	142.09%
Change from open	0.04%
Day's gap	0.07%
Dollar volume	$35.4M
High price	$13.78
Low price	$13.75
Monthly RSI	51.24
Open price	$13.76
Position in 52-week range	50%
Previous close	$13.75
Price vs 150-day SMA	8.03%
Price vs 20-day SMA	0.17%
Price vs 200-day SMA	20.16%
Price vs 50-day SMA	0.31%
Relative volume	1.16
RSI	57.79
Sharpe ratio	1.33
Sharpe ratio (3Y)	0.2
Sharpe ratio (5Y)	-0.17
Sortino ratio	3.38
Sortino ratio (3Y)	0.41
Sortino ratio (5Y)	-0.13
Volume	2.6M
Weekly RSI	69.61
YTD price change	92.12%
YTD total return	93.17%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	243M
Float percentage	92.55%
Shares change (QoQ)	2.87%
Shares change (YoY)	1.39%
Shares held by insiders	0.47%
Shares held by institutions	77.55%
Shares outstanding	262.6M
Short % of float	7.8%
Short % of shares	7.22%
Short ratio	7.1 days

Deeper analysis on OGN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this OGN report

Is a complete OGN research report available?

No complete published report is available for Organon & Co. (OGN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Organon & Co. (OGN)

Price

Financial snapshot

Fair-value bridge

Latest news · OGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All OGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on OGN

Frequently asked questions